Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1Gastrointestinal 1CNS 1Breast 1

Conditions

Urogenital Neoplasms 1Neoplasms, Unknown Primary 1Head and Neck Neoplasms 1Digestive System Neoplasms 1Central Nervous System Neoplasms 1Breast Neoplasms 1Brain Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 6Radiotherapy 3Fluorodeoxyglucose F18 3entrectinib 2IFL protocol 2FAPI-46 2Cisplatin 2Bevacizumab 2tipifarnib 1regorafenib 1pembrolizumab 1fluoromisonidazole 1entinostat 1cc-486 1brodalumab 1alectinib 1aflibercept 1Triiodothyronine 1Trastuzumab 1Thyroxine 1Thiotepa 1Thalidomide 1Tamoxifen 1Ritonavir 1Quality of Life 1Psychology, Positive 1Proton Therapy 1Peripheral Blood Stem Cell Transplantation 1Patient-Specific Modeling 1Patient Reported Outcome Measures 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Brain Neoplasms × Genetic Counseling × Head & Neck × Clear all
NCT04456140 2023-07-24

Pro-Active Genetic Testing in Patients With Solid Tumors, Inherit Study

Mayo Clinic

Phase 1 Completed
230 enrolled
BreastCNSGastrointestinalHead & Neck

Brain Neoplasms, Breast Neoplasms, Digestive System Neoplasms, Head and Neck Neoplasms, Neoplasms, Unknown Primary, Urogenital Neoplasms, Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡